In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 26, 292-300
Abstract
No abstract availableKeywords
Funding Information
- Meso Scale Diagnostics
- Shionogi
- Pfizer
This publication has 26 references indexed in Scilit:
- Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2016
- The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones ofKlebsiella pneumoniaeST11/KPC-2, ST101/KPC-2 and ST512/KPC-3Journal of Antimicrobial Chemotherapy, 2016
- Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant CarbapenemasesAntimicrobial Agents and Chemotherapy, 2016
- In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant StrainsAntimicrobial Agents and Chemotherapy, 2016
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteriaJournal of Antimicrobial Chemotherapy, 2015
- The increasing threat of Pseudomonas aeruginosa high-risk clonesDrug Resistance Updates, 2015
- Ceftazidime-Avibactam Activity Tested against Enterobacteriaceae Isolates from U.S. Hospitals (2011 to 2013) and Characterization of β-Lactamase-Producing StrainsAntimicrobial Agents and Chemotherapy, 2015
- A review on colistin nephrotoxicityEuropean Journal of Clinical Pharmacology, 2015
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteriaFrontiers in Microbiology, 2014
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic PathogenClinical Microbiology Reviews, 2012